RCE in Proofpoint Enterprise Protection

CVE-2023-0089

The webutils in Proofpoint Enterprise Protection (PPS/POD) contain a vulnerability that allows an authenticated user to execute remote code through 'eval injection'. This affects all versions 8.20.0 and below.

Published · last modified .

CVSS v3 metric

CVSS v3 base score 8.8 (High). Vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H.

EPSS exploit prediction

EPSS: 0.007 (52.8th percentile), scored .

Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 53rd percentile — 52.8% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.

EPSS trend (30 days)EPSS over the last 30 days for CVE-2023-0089: held from 0.007 to 0.007.

EPSS over last 30 days · oldest: 0.007 · newest: 0.007 · change: 0.000

Affected products

Weakness classification (CWE)

Public proof-of-concept exploits

References

Frequently asked questions

What is CVE-2023-0089?
CVE-2023-0089 is a high-severity vulnerability in Proofpoint Enterprise Protection, classified under Eval Injection. CVSS score: 8.8/10. Published 2023-03-08.
How severe is CVE-2023-0089?
High severity. CVSS v3 base score is 8.8 out of 10.
Is CVE-2023-0089 known to be exploited?
1 public proof-of-concept repositories are indexed. Not currently listed in the CISA KEV catalog.